IMP3 as a cytoplasmic biomarker for early serous tubal carcinogenesis

IMP3 as a cytoplasmic biomarker for early serous tubal carcinogenesis

BACKGROUND:Serous tubal intraepithelial carcinoma (STIC) and the p53 signature in tubal mucosa have been supported to be precursor lesions in high-grade serous carcinoma (HGSC) of the fallopian tube, ovary, and peritoneum. It remains critical to find biomarkers for precursor lesions in order to dete...

Full description

Bibliographic Details
Main Authors:	Wang, Yiying, Li, Lingmin, Wang, Yue, Yuan, Zeng, Zhang, Wenjing, Hatch, Kenneth, Zheng, Wenxin
Other Authors:	Department of Obstetrics and Gynecology, Henan Provincial People’s Hospital, Zhengzhou, China
Language:	en
Published:	BioMed Central 2014
Subjects:	IMP3 Serous tubal intraepithelial carcinoma STIC p53 signature High-grade serous carcinoma
Online Access:	Wang et al. Journal of Experimental & Clinical Cancer Research 2014, 33:60 http://www.jeccr.com/content/33/1/60 http://hdl.handle.net/10150/610179 http://arizona.openrepository.com/arizona/handle/10150/610179

Similar Items

IMP3 signatures of fallopian tube: a risk for pelvic serous cancers
by: Wang, Yiying, et al.
Published: (2014)

High grade serous ovarian carcinoma with serous tubal intraepithelial carcinoma in a case presented with atypical glandular cell favor neoplasm cervical cytology and dermatomyositis
by: Mun-Kun Hong, et al.
Published: (2015-04-01)

Low grade serous carcinoma of the peritoneum in a BRCA1 carrier previously diagnosed with a “low-grade serous tubal intra-epithelial carcinoma” (STIC) on risk reducing surgery
by: Wen Yee Chay, et al.
Published: (2015-04-01)

Proteomic Analysis of Pre-Invasive Serous Lesions of the Endometrium and Fallopian Tube Reveals Their Metastatic Potential
by: Mitchell Acland, et al.
Published: (2020-12-01)

Secretory cell outgrowths, p53 signatures, and serous tubal intraepithelial carcinoma in the fallopian tubes of patients with sporadic pelvic serous carcinoma
by: Neha Mittal, et al.
Published: (2016-01-01)

Cytologic studies of the fallopian tube in patients undergoing salpingo-oophorectomy
by: Chen, Hao, et al.
Published: (2016)

Cell Origins of High-Grade Serous Ovarian Cancer
by: Jaeyeon Kim, et al.
Published: (2018-11-01)

CD105 Is Expressed in Ovarian Cancer Precursor Lesions and Is Required for Metastasis to the Ovary
by: Shoumei Bai, et al.
Published: (2019-11-01)

Development of Peritoneal Carcinoma in women diagnosed with Serous Tubal Intraepithelial Carcinoma (STIC) following Risk-Reducing Salpingo-Oophorectomy (RRSO)
by: P. I. Stanciu, et al.
Published: (2019-05-01)

Concurrent isolated retroperitoneal HGSC and STIC defined by somatic mutation analysis: a case report
by: Kazuaki Suda, et al.
Published: (2019-02-01)

Advances in Tumor Screening, Imaging, and Avatar Technologies for High-Grade Serous Ovarian Cancer
by: Anders eOhman, et al.
Published: (2014-11-01)

Ovarian serous carcinoma: recent concepts on its origin and carcinogenesis
by: Li Jie, et al.
Published: (2012-03-01)

Ovarian serous carcinoma: recent concepts on its origin and carcinogenesis
by: Li, Jie, et al.
Published: (2012)

A case of synchronous serous ovarian cancer and uterine serous endometrial intraepithelial carcinoma
by: Maho Shimizu, et al.
Published: (2021-06-01)

Bilateral Primary Papillary Serous Carcinoma of the Fallopian Tube
by: H.K. Manjunatha, et al.
Published: (2017-05-01)

High-grade serous carcinoma with discordant p53 signature: report of a case with new insight regarding high-grade serous carcinogenesis
by: Yuichiro Hatano, et al.
Published: (2018-04-01)

Back to the Future? The Fallopian Tube, Precursor Escape and a Dualistic Model of High-Grade Serous Carcinogenesis
by: T. Rinda Soong, et al.
Published: (2018-11-01)

Salpingectomy and prevention of ovarian carcinoma
by: Shahul Hameed Mohamed Siraj, et al.
Published: (2016-08-01)

High-grade versus low-grade serous carcinoma of the ovary – current differential diagnosis and perspectives
by: Manuela POPA, et al.
Published: (2018-12-01)

The prevalence of occult ovarian cancer in the series of 155 consequently operated high risk asymptomatic patients – Slovenian population based study
by: Gornjec Andreja, et al.
Published: (2020-05-01)

Importance of serous intraepithelial ovarian tubal carcinomas in the occurrence of "high-grade" serous carcinomas and / or peritoneal serous carcinomas of unknown primary origin.
by: I. S. Shponka, et al.
Published: (2020-04-01)

Endometrial intraepithelial carcinoma: A case report and brief review
by: Ram Manisha, et al.
Published: (2008-10-01)

Low-grade serous carcinoma with extensive osseous metaplasia arising from ovarian serous cystadenofibroma
by: Renan Ribeiro e Ribeiro, et al.
Published: (2021-05-01)

The poor prognosis of sarcomatoid carcinoma arising from low grade serous ovarian cancer: A case report and review of the literature
by: Paulina Haight, et al.
Published: (2021-05-01)

Morphological basics of ovarian tumor histogenesis
by: F. V. Novikov, et al.
Published: (2020-06-01)

Paraneoplastic myositis secondary to poorly differentiated serous carcinoma of ovarian/tubal origin
by: Zachary Raizman, et al.
Published: (2017-05-01)

A 4-gene signature predicts prognosis of uterine serous carcinoma
by: Hui Chen, et al.
Published: (2021-02-01)

The Molecular Fingerprint of High Grade Serous Ovarian Cancer Reflects Its Fallopian Tube Origin
by: Thomas Meyer, et al.
Published: (2013-03-01)

Mechanisms of High-Grade Serous Carcinogenesis in the Fallopian Tube and Ovary: Current Hypotheses, Etiologic Factors, and Molecular Alterations
by: Isao Otsuka
Published: (2021-04-01)

CT features of low grade serous carcinoma of the ovary
by: Harpreet K. Pannu
Published: (2015-01-01)

High-grade serous ovarian carcinoma with mucinous differentiation: report of a rare and unique case suggesting transition from the “SET” feature of high-grade serous carcinoma to the “STEM” feature
by: Yuichiro Hatano, et al.
Published: (2019-01-01)

Overexpression and oncogenic function of HMGA2 in endometrial serous carcinogenesis
by: Wei, Linxuan, et al.
Published: (2016)

Comprehensive genomic profiling of high‐grade serous ovarian carcinoma from Chinese patients identifies co‐occurring mutations in the Ras/Raf pathway with TP53
by: Fangfang Zhong, et al.
Published: (2019-07-01)

Cytology positive pericardial effusion causing tamponade in patients with high grade serous carcinoma of the ovary
by: Joni Kooy, et al.
Published: (2020-08-01)

KRAS/BRAF Analysis in Ovarian Low-Grade Serous Carcinoma Having Synchronous All Pathological Precursor Regions
by: Kohei Nakamura, et al.
Published: (2016-04-01)

Testicular serous carcinoma of ovarian epithelial type
by: Chang-Hong Yeh, et al.
Published: (2017-06-01)

Synchronous Primary Serous Carcinoma of the Endometrium and Bilateral Ovaries
by: Shivali Sehgal, et al.
Published: (2017-07-01)

Late recurrence of pStage 1 low-grade serous ovarian tumor presenting as a symptomatic bone metastasis: a case report
by: Chiaki Kubo, et al.
Published: (2018-06-01)

STING pathway expression in low‐grade serous carcinoma of the ovary: an unexpected therapeutic opportunity?
by: Jutta Huvila, et al.
Published: (2021-11-01)

Differences between primary peritoneal serous carcinoma and advanced serous ovarian carcinoma: a study based on the SEER database
by: Xiaoduo Li, et al.
Published: (2021-02-01)